Skincare investment opportunity 3M raise The business is a premium skincare business focused on problematic and sensitive skin, with clinic-grade products already tested and ready for broad commercial rollout. Key Highlights • £4.2M projected revenue this year • Returning Customer rate = 31% • AQUIOL ™ patent for a 20-year license • Non-Steroidal Solutions • Targeting the root of the cause • Safe for problematic skin • 4 independent tests completed – no trace of THC was found • New website launching next week • 10+ new derma products launching between this summer and next summer. • Strong demand for masks, cleansers, lifters and skin repair products. • Commercial Expansion Rolling out across: • United Kingdom • Central Europe • France • Germany • Ireland • Mexico • United States Distribution Progress • France target: 50–60 stores (June/July) • Get Harley meeting this week (1,500 clinic network) • PR agency with access to 40 clinics • Navi Group (3–5 stores) • Early talks with John Lewis • Investment Case This combines clinical credibility, recurring consumer demand, international growth channels, and near-term revenue momentum. Now entering a key commercial scale-up phase. Investment Raise €1.5 Million at a €15M Valuation Allocation 35% Marketing & Digital Growth 20% Commercial Rollout 15% Working Capital & Inventory 10% Operations & team expansion 10% Clinical Study 10% Platform & Infrastructure